News | Harbor Healthcare Consultants

2026 LTC Pharmacy M&A Special Report

The long-term care pharmacy sector is undergoing meaningful transformation, supported by favorable demographic trends, evolving care models and continued healthcare consolidation. While implementation of the Inflation Reduction Act created reimbursement uncertainty and temporarily tempered transaction activity in late 2025 and early 2026

Harbor Healthcare Announces the Sale of Patient Care Behavioral Health Pharmacy

Nevada — Harbor Healthcare Consultants (“Harbor”), a boutique investment bank specializing in healthcare M&A, today announced that it served as the exclusive M&A advisor to Patient Care Pharmacy (“Patient Care” or the “Company”), a behavioral health and long-term care pharmacy based in Nevada. Over the years, Patient Care Pharmacy has grown into a leading medication […]

Harbor Healthcare Announces the Sale & Partnership of Potter’s House Apothecary

PEORIA, AZ. – Harbor Healthcare Consultants is pleased to announce the sale and strategic partnership of Potter’s House Apothecary, a respected provider of sterile and nonsterile compounded medications, to a venture backed healthcare enterprise. Harbor Healthcare Consultants served as the exclusive M&A advisor to Potter’s House Apothecary. The terms of the transaction were not disclosed. […]

Harbor Healthcare Advises The Healthy Choice Compounding Pharmacy on its Sale

New York, NY – Harbor Healthcare Consultants, acting as the exclusive sell-side advisor, today announced the successful completion of the sale of The Healthy Choice Compounding Pharmacy, a New York-based non-sterile 503A compounding pharmacy. The transaction represents another successful closing for Harbor Healthcare Consultants in the growing anti-aging and wellness pharmacy sector. The Healthy Choice […]

2026 Compounding Pharmacy – Key M&A Considerations for Sellers

Compounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price simply rearrange the deck chairs on the Titanic. Customer relationships and provider trust drive enterprise value. Sellers must clearly understand the core assets of their company and how the market values them—because when buyers control […]

Harbor Healthcare Advises Midwest Compounders Pharmacy on its Sale

Lenexa, Kansas – Harbor Healthcare is pleased to announce the sale of Midwest Compounders, a 503A sterile compounding pharmacy based in Lenexa, Kansas, to a strategic healthcare investor recognized for deep industry expertise and national relationships. The compounding pharmacy segment has experienced rapid growth over the past decade as integrative medicine has gained recognition and […]

Harbor Healthcare Announces the Sale of Mercury LTC Pharmacy

Harbor Healthcare Consultants is pleased to announce it served as the exclusive sell-side advisor to Mercury Pharmacy Services, a premier long-term care (LTC) pharmacy based in Mountlake Terrace, Washington, in its sale to Guardian Pharmacy Services, one of the nation’s largest LTC pharmacy operators. Founded in 2003, Mercury Pharmacy Services has built a strong regional […]

2025 Private Equity Update – Healthcare Services & Pharmacy

Other private equity investors might acquire a target to enhance their purchasing power. For example, in the case of a leveraged buyout, the private equity fund would borrow additional money to increase its buying power, using the target acquisition’s assets as collateral. In other cases, the acquisition could grant preferential pricing with key vendors, reducing […]

Harbor Healthcare Announces The Sale Of Meta Pharmacy Services

Nevada – Harbor Healthcare is pleased to announce the sale and partnership of Meta Pharmacy Services, a distinguished 503A nationwide compounding pharmacy providing advanced anti-aging and integrative therapies. The acquirer, a private investor, brings further resources and acumen to the pharmacy. The collaboration signifies a pivotal advancement for the company; one that will foster growth […]

Harbor Healthcare Announces The Sale of a 50,000 sqft 503A Compounding Pharmacy

Missouri – Harbor Healthcare Mergers & Acquisitions, a leading advisory firm specializing in compounding pharmacy transactions, is pleased to announce the successful sale of a 50,000 sqft 503A non-sterile compounding pharmacy, to a nationwide strategic acquirer. The transaction marks an important step in expanding the buyer’s operational capacity and capabilities, enabling broader geographic reach and […]

A much deserved yet overdue thank you for your continued help and support of me with the questions that I ask of you from time to time. I appreciate your patience and perseverance in ensuring that you find the right answer for me.
Jeffrey E. Feldberg
Choosing someone that could mentor me with all of the nuances of this type of business was important. I was very fortunate to find Mark who has been instrumental in helping me understand not only what needed to be done but also how to accomplish it in the most effective, efficient way.
Tammy Miller
Being a pharmacist himself and owning his own businesses provides Ira with unique insight when working on behalf of a pharmacy owner… While working on my behalf, I observed several of Ira’s personality characteristics which helped create and keep the deal together; these being: people skills, positive attitude, decisiveness, creativity and intellect. In addition, during the transaction Ira was able to gain the respect of our prospective buyers with his expertise and style…
Ronald A. Memo, RPh
Ira Cammeyer is not a “business broker”. He and his colleagues are deal makers. They maximize your position in the market and represent you 110%. The association does not stop after the deal is done. Belonging to the “Ira” family brings you opportunities in the future. In addition, Ira is there for you. His opinion and network is just a phone call away.
Stanley R. Goldenberg, RPh, FASCP
Michael worked tirelessly in establishing financials that would convert our private business records into the format required for evaluation by potential capital partners. We could not be more pleased by the results and will continue our relationship with Harbor Healthcare so that they can assist us in finding potential acquisition targets.
Ron Belville, RPh

Harbor Healthcare Consultants News